RecruitingNot ApplicableNCT06009588
Comparison of Self- and Balloon-expandable Valves in Patients With Ascending Aortic Dilation Undergoing Transcatheter Aortic Valve Replacement: The AAD-CHOICE
Sponsor
China National Center for Cardiovascular Diseases
Enrollment
100 participants
Start Date
Aug 31, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
This study aimed at comparing the performance of self-expandable valves versus balloon-expandable valves in patients with ascending aortic dilation undergoing transcatheter aortic valve replacement.
Eligibility
Min Age: 65 Years
Inclusion Criteria5
- Severe aortic stenosis;
- Transfemoral access;
- Preoperative aortic CT suggesting maximum ascending aortic diameter ≥45mm and <55mm;
- Anticipated life expectancy >1 year;
- Age ≥ 65 years.
Exclusion Criteria4
- Dominant aortic regurgitation,;
- A history of SAVR or TAVR;
- A history of aortic surgery;
- Emergent TAVR.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEself-expandable valves
patients undergoing TAVR use self-expandable valves
DEVICEballoon-expandable valves
patients undergoing TAVR use balloon-expandable valves
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06009588
Related Trials
Comparison of Evolut FX Versus Sapien 3 Ultra Resilia.
NCT064700221 location
Transcatheter AortiC Valve Implantation in aorTic stenosIs CardiogenIc Shock
NCT066382681 location
DELINEATE-Prospective
NCT071977361 location
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
NCT05646381139 locations
STAR Trial (Siegel Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis)
NCT072783101 location